Moors & Cabot’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$395K Buy
7,544
+427
+6% +$16.7K 0.02% 642
2026
Q1
$252K Buy
+7,117
New +$221K 0.01% 775
2025
Q4
– Sell
-6,777
Closed -$203K – 927
2025
Q3
$203K Buy
+6,777
New +$191K 0.01% 839
2025
Q2
– Sell
-8,604
Closed -$284K – 888
2025
Q1
$284K Sell
8,604
-393
-4% -$12.8K 0.01% 656
2024
Q4
$259K Buy
8,997
+1,028
+13% +$29.6K 0.01% 714
2024
Q3
$223K Buy
+7,969
New +$212K 0.01% 754

Other funds holding ALKS

Moors & Cabot's ALKS Position: Q2 2026 in Review

Moors & Cabot increased its Alkermes (ALKS) stake by 6% in Q2 2026, buying an estimated $16.7K and bringing the position to 7,544 shares worth $395K. The position accounts for 0.02% of the portfolio, ranked #642.

Moors & Cabot first reported a position in ALKS in Q3 2024 and has held it in 6 quarters since. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Moors & Cabot held 7,544 shares of Alkermes worth $395K as of Q2 2026.
  • Moors & Cabot bought 427 Alkermes shares in Q2 2026, an estimated $16.7K.
  • Alkermes made up 0.02% of Moors & Cabot's portfolio in Q2 2026, its #642 holding.
  • Moors & Cabot first reported a position in Alkermes in Q3 2024 and has held it in 6 quarters since.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Moors & Cabot's 13F filing for Q2 2026, filed 10 Aug 2026.